References
- Dong H, Chen SX, Hu HX, Kadota S, Namba T. 1998. A new antiplatelet diarylheptanoid from Alpinia blepharocalyx. J Nat Prod. 61(1):142–144.10.1021/np970293i
- Gao SY, Xia GY, Wang LQ, Zhou L, Zhao F, Huang J, Chen LX. 2017. Sesquiterpenes from Curcuma wenyujin with their inhibitory activities on nitric oxide production in RAW 264.7 cells. Nat Prod Res. 31(5):548–554.10.1080/14786419.2016.1205053
- Kim JA, Son JK, Chang HW, Jahng Y, Kim Y, Na M, Lee SH. 2008. Inhibition of mushroom tyrosinase and melanogenesis B16 mouse melanoma cells by components isolated from Curcuma longa. Nat Prod Commun. 3(10):1655–1658.
- Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y. 1993. Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem Pharm Bull. 41:1640–1643.10.1248/cpb.41.1640
- Li SY, Yuan W, Deng GR, Wang P, Yang PY, Aggarwal BB. 2011. Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharm Crops. 2:28–54.10.2174/2210290601102010028
- Manzan ACCM, Toniolo FS, Bredow E, Povh NP. 2003. Extraction of essential oil and pigments from Curcuma longa L. by steam distillation and extraction with volatile solvents. J Agric Food Chem. 51(23):6802–6807.10.1021/jf030161x
- Masuda T, Jitoe A, Isobe J, Nakatani N, Yonemori S. 1993. Anti-oxidative and anti-inflammatory curcumin-related phenolics from rhizomes of Curcuma domestica. Phytochem. 32:1557–1560.10.1016/0031-9422(93)85179-U
- Mirzaei H, Naseri G, Rezaee R, Mohammadi M, Banikazemi Z, Mirzaei HR, Salehi H, Peyvandi M, Pawelek JM, Sahebkar A. 2016. Curcumin: a new candidate for melanoma therapy? Int J Cancer. 139(8):1683–1695.10.1002/ijc.v139.8
- Panahi Y, Sahebkar A, Parvin S, Saadat A. 2012. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann Clin Biochem. 49:580–588.10.1258/acb.2012.012040
- Panahi Y, Ghanei M, Bashiri S, Hajihashemi A, Sahebkar A. 2015. Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: positive results of a randomized double-blind placebo-controlled trial. Drug Res. 65(11):567–573.
- Rameshkumar KB, Alan Sheeja DB, Nair Mangalam S, George V. 2015. Curcuma ecalcarata - new natural source of pinocembrin and piperitenone. Nat Prod Res. 29(13):1276–1279.10.1080/14786419.2014.994210
- Sahebkar A. 2014. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis Phytother Res. 28(5):633–642.10.1002/ptr.v28.5
- Sarkar A, De R, Mukhopadhyay AK. 2016. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases. World J Gastroenterol. 22(9):2736–2748.10.3748/wjg.v22.i9.2736
- Sun CP, Qiu CY, Yuan T, Nie XF, Sun HX, Zhang Q, Li HX, Ding LQ, Zhao F, Chen LX, Qiu F. 2016. Antiproliferative and anti-inflammatory withanolides from Physalis angulata. J Nat Prod. 79(6):1586–1597.10.1021/acs.jnatprod.6b00094
- Sun W, Wang S, Zhao WW, Wu CH, Guo SH, Gao HW, Tao HX, Lu JJ, Wang YT, Chen XP. 2017. Chemical constituents and biological research on plants in the genus Curcuma. Crit Rev Food Sci Nutr. 57(7):1451–1523.10.1080/10408398.2016.1176554
- Uehara S, Yasuda I, Takeya K, Itokawa H, Iitaka Y. 1990. New bisabolane sesquiterpennoids from the rhizomes of Curcuma xanthorrhiza (Zingiberaceae) II. Chem Pharm Bull. 38(1):261–263.10.1248/cpb.38.261
- Zeng YC, Qiu F, Takahashi K, Liang JM, Qu GX, Yao XS. 2007a. New sesquiterpenes and calebin derivatives from Curcuma longa. Chem Pharm Bull. 55(6):940–943.10.1248/cpb.55.940
- Zeng YC, Liang JM, Qu GX, Qiu F. 2007b. Chemical constituents of Curcuma longa I : bisabolane sesquiterpenes. Chin J Med Chem. 17(4):238–241.
- Zeynep K, Işıl G, Erim FB. 2017. Comparison of antioxidant, anticholinesterase, and antidiabetic activities of three curcuminoids isolated from Curcuma longa L. Nat Prod Res. 1–4. doi:10.1080/14786419.2017.1299727.